Ways Back to Work: facilitating the return to work of NHS staff with common mental health disorders

Facilitating the return to work of NHS staff with common mental health disorders: a feasibility study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14621901

Enrollment

Registered

2018-08-10

Start date

2018-02-01

Completion date

Unknown

Last updated

2022-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common mental health disorders (depression, anxiety, stress) Mental and Behavioural Disorders Common mental health disorders (depression, anxiety, stress)

Interventions

Allocation of sites to either ‘intervention’, ‘mixed intervention/ care as usual’ or ‘care as usual only’ arm will not be undertaken using a randomisation method. Rather, this will be influenced by wh

who have been off sick from work for more than 7 days and fewer than 90 days. The feasibility of delivering a novel case management approach will be compared to standard care. The case-management appr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. NHS staff 2. Common mental health disorder (CMHD) with or without an associated physical disorder 3. Off sick from work for more than 7 days and fewer than 90 days 4. Off sick when: 4.1. Referral made to Occupational Health (OH) 4.2. Completing baseline questionnaire

Exclusion criteria

Exclusion criteria: 1. Psychotic disorder 2. Bipolar disorder 3. Substance misuse disorder 4. Dementia 5. Under investigation for misconduct or in the process of formal disciplinary action.

Design outcomes

Primary

Measure	Time frame
1. Feasibility of the intervention, assessed at the end of the study once all data has been analysed: 1.1. Rates of uptake among those eligible to participate 1.2. Frequency and nature of protocol violations, assessed throughout the study period from file note data, feedback from sites and during the qualitative component (e.g. whether there were any difficulties in implementing the protocol) 1.3. Completeness of data collection, assessed through a final report at the end of the study from the trial statistician detailing the extent of missing data 1.4. Average consultation times compared to normal, assessed at the end of the study using the 'care as usual' and 'case management' data collection forms 1.5. Mean number of follow-ups per case, assessed at the end of the study using the 'care as usual' and 'case management; data collection forms 1.6. Extra line manager and human resource time per consultation compared to normal, captured during qualitative data collection 1.7. Fidelity of the case-manager training, assessed using the 'case management' data collection form 1.8. Adherence to the intervention in those allocated to receive it 2. Acceptability of the intervention, assessed during qualitative data collection: 2.1. A summary of qualitative findings representing views on the intervention and its assessment expressed by participants, case-managers, HR and line-managers. All qualitative data will be transcribed and thematic analysis will be undertaken. The findings of this will be outlined in the final study report. 2.2. Reasons for not completing the intervention and any adverse effects, assessed throughout the study using the serious adverse events form, the withdrawal form, participant questionnaire parts C and D, along qualitative interviews. 3. Measurements of costs of	—

Measure

Time frame

1. Feasibility of the intervention, assessed at the end of the study once all data has been analysed: 1.1. Rates of uptake among those eligible to participate 1.2. Frequency and nature of protocol violations, assessed throughout the study period from file note data, feedback from sites and during the qualitative component (e.g. whether there were any difficulties in implementing the protocol) 1.3. Completeness of data collection, assessed through a final report at the end of the study from the trial statistician detailing the extent of missing data 1.4. Average consultation times compared to normal, assessed at the end of the study using the 'care as usual' and 'case management' data collection forms 1.5. Mean number of follow-ups per case, assessed at the end of the study using the 'care as usual' and 'case management; data collection forms 1.6. Extra line manager and human resource time per consultation compared to normal, captured during qualitative data collection 1.7. Fidelity of the case-manager training, assessed using the 'case management' data collection form 1.8. Adherence to the intervention in those allocated to receive it 2. Acceptability of the intervention, assessed during qualitative data collection: 2.1. A summary of qualitative findings representing views on the intervention and its assessment expressed by participants, case-managers, HR and line-managers. All qualitative data will be transcribed and thematic analysis will be undertaken. The findings of this will be outlined in the final study report. 2.2. Reasons for not completing the intervention and any adverse effects, assessed throughout the study using the serious adverse events form, the withdrawal form, participant questionnaire parts C and D, along qualitative interviews. 3. Measurements of costs of

—

Countries

England, United Kingdom

Contacts

Public ContactIra Madan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 16, 2026